Monday, July 13, 2026 Live from SEC EDGAR

The Wire Leaderboards Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GRML — Greenland Mines Ltd SEC Filings | FilingIndex

GRMLNasdaq

Greenland Mines Ltd

Biological Products, (No Diagnostic Substances) · CIK 1907223

Greenland Mines Ltd develops medicines for chronic diseases and mines critical minerals

red 8-K · 90d

+ Watch View on EDGAR ↗

$35M

Market cap

$0.24

Last close

+1.2%

1D

+5.6%

5D

2.0M

Volume

Price$0.24-47.7%· 6M

Volume

Mar 12L $0.21 · H $0.52Jul 10

Fundamentals & quality

Fundamentals not yet available for this company.

Similar companies

Comparable business profile · signals at a glance

CLNNClene Inc.$77.9M+0.3%GANXGain Therapeutics, Inc.$81.5M-1.1%ACOGAlpha Cognition Inc.$171.8M-1.3%GPCRStructure Therapeutics Inc.$3.8B-3.2%RYTMRHYTHM PHARMACEUTICALS, INC.

Filings archive

Newest first · each with a one-line AI read · showing 10 of 125

Jul 8, 20268-KAuditor ChangeGreenland Mines Ltd. terminated its At-the-Market Sales Agreement with A.G.P./Alliance Global Partners, effective July 4, 2026. No shares remain available for sale under this agreement.Jun 29, 20268-KAuditor ChangeGreenland Mines Ltd. dismissed its independent registered public accounting firm, BCRG Group, and appointed Simon & Edward LLP as its new independent registered public accounting firm. This change was effective June 23, 2026, following Simon & Edward LLP's acquisition of BCRG Group's attest business.Jun 25, 20268-KEquity IssuanceGreenland Mines Ltd. completed a private placement of its common stock on June 18, 2026, raising approximately $3,750,000. This transaction was conducted under an exemption from registration requirements.

$7.8B

-6.1%

CGTXCOGNITION THERAPEUTICS INC$104.7M0.0%

Jun 22, 2026DEF 14APROXY STATEMENTGreenland Mines Ltd. is holding a Special Meeting of Stockholders on July 16, 2026, to vote on three proposals. These proposals include approving the issuance of shares related to a recent acquisition and a private placement, increasing the shares available under the 2024 Equity Incentive Plan, and allowing for meeting adjournments. The Board of Directors unanimously recommends voting "FOR" all proposals.

Jun 22, 20268-KMaterial Agreement · Equity IssuanceGreenland Mines Ltd. entered into a Share Exchange Agreement with AnorTech Inc. to acquire a minority stake in AnorTech, issuing its own shares in exchange. The agreement also includes an option for Greenland Mines to acquire additional AnorTech shares.

Jun 22, 20268-KShareholder VoteGreenland Mines Ltd. held a special meeting of stockholders on June 18, 2026, where shareholders approved a proposal to amend the company's certificate of incorporation to effect one or more reverse stock splits. The approved reverse stock splits can have an exchange ratio between 1-for-2 and 1-for-50, with an aggregate exchange ratio not exceeding one-for-60, as determined by the Board of Directors.

Jun 17, 20268-KMaterial AgreementGreenland Mines Ltd. entered into a Securities Purchase Agreement to sell 15,000,000 shares of common stock for total proceeds of $3,750,000. The closing is expected on or before June 25, 2026.

May 26, 2026DEF 14APROXY STATEMENTGREENLAND MINES LTD is holding a Special Meeting of Stockholders on June 18, 2026, to vote on a proposal to authorize the Board of Directors to effect one or more reverse stock splits of the Company's common stock, with an aggregate exchange ratio not exceeding 1-for-60, and to approve the adjournment of the meeting if necessary.

May 21, 20268-KMaterial AgreementGreenland Mines Ltd entered into a merger agreement with Neo North Star Resources, Inc. on May 20, 2026, to acquire Neo North Star through a merger with a subsidiary. The total consideration for the merger is $35,000,000, payable in cash and newly issued shares of Greenland Mines Ltd's common stock.

May 20, 202610-QQUARTERLY REPORTGreenland Mines Ltd. reported a net loss of $13,857,203 for the quarter ended March 31, 2026, a significant increase from the prior year's loss of $2,116,726, driven by higher operating expenses and an impairment charge. The company has substantial accumulated deficits and faces substantial doubt about its ability to continue as a going concern without additional funding.

Show 50 more ↓

May 19, 20268-K/ACompany UpdateThis filing is an amendment to a previous report, clarifying that financial statements for the acquired Greenland Mines, Inc. are not required because the acquired assets do not constitute a business under Rule 3-05 of Regulation S-X. The original report was filed on March 10, 2026, and this amendment was filed on May 19, 2026.May 14, 20268-KReg FD DisclosureGreenland Mines Ltd is providing an investor presentation on May 14, 2026, and a related press release was issued on May 13, 2026. The presentation materials are furnished as an exhibit.Apr 22, 20268-KExecutive ChangeGreenland Mines Ltd. appointed Jason D. Sawyer to its Board of Directors on April 17, 2026, to fill a vacancy. Mr. Sawyer has extensive experience in the alternative investment industry.Apr 1, 202610-KANNUAL REPORTGreenland Mines Ltd. is a clinical-stage biotechnology company focused on developing gene therapies for neurodegenerative diseases and biosimilars for cancer treatment. The company reported a net loss of $10,551,674 for the year ended December 31, 2025, and has a substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows.Mar 23, 20268-KReg FD Disclosure · Company UpdateGreenland Mines Ltd received a six-month extension from The Nasdaq Stock Market LLC to regain compliance with the Bid Price Rule, with a new deadline of September 14, 2026. Failure to comply by this date could result in the delisting of the Company's common stock from Nasdaq.Mar 16, 20268-KBylaw Amendment · Reg FD DisclosureThe company, formerly Klotho Neurosciences, Inc., completed a merger with its subsidiary on March 11, 2026, which resulted in a name change to Greenland Mines Ltd. The company's stock began trading under a new symbol on March 12, 2026.Mar 12, 20268-KReg FD DisclosureGreenland Mines Ltd, formerly Klotho Neurosciences, Inc., will host an investor presentation on March 12, 2026, at 4:15 PM Eastern Daylight Time, via a publicly accessible webcast. Presentation materials are furnished as an exhibit.Mar 10, 20268-KMaterial Agreement · Acquisition / DispositionKlotho Neurosciences, Inc. completed a merger transaction on March 4, 2026, acquiring Greenland Mines Corp. and its interest in mineral properties in Greenland. The company also designated a new Series C Preferred Stock.Mar 4, 20268-KReg FD DisclosureKlotho Neurosciences, Inc. announced its acquisition of Greenland Mines Corp. on March 4, 2026. The details of this acquisition are provided in an attached press release.Mar 2, 20268-KEquity IssuanceKlotho Neurosciences, Inc. completed a private placement of common stock and warrants, raising approximately $7,750,000 in gross proceeds. The company issued shares and warrants to purchasers who represented themselves as accredited investors.Feb 24, 20268-KMaterial AgreementKlotho Neurosciences, Inc. entered into a Securities Purchase Agreement to issue and sell common stock and warrants to 10 investors. The closing is expected to occur on or before March 15, 2026.Feb 17, 20268-KShareholder VoteKlotho Neurosciences, Inc. held a special meeting of stockholders on February 17, 2026, where shareholders approved a reverse stock split and an amendment to the 2024 Equity Incentive Plan.Jan 23, 2026DEF 14APROXY STATEMENT Dec 8, 20258-KMaterial Agreement · Equity Issuance Dec 5, 2025S-1REGISTRATION STATEMENT Nov 13, 202510-QQUARTERLY REPORT Sep 25, 20258-KMaterial Agreement Sep 25, 20258-KDelisting Notice Aug 18, 202510-QQUARTERLY REPORT Aug 12, 20258-KMaterial Agreement · Reg FD Disclosure Jul 28, 2025424B5PROSPECTUS SUPPLEMENT Jul 23, 20258-K/AExecutive Change Jul 22, 20258-KMaterial Agreement · Reg FD Disclosure Jul 18, 20258-KDelisting Notice · Reg FD Disclosure Jul 10, 20258-KReg FD Disclosure Jun 30, 20258-KReg FD Disclosure Jun 16, 20258-KReg FD Disclosure · Company Update Jun 13, 20258-KMaterial Agreement · Equity Issuance Jun 11, 20258-KMaterial Agreement · Equity Issuance Jun 10, 20258-KMaterial Agreement · Equity Issuance Jun 2, 20258-KShareholder Vote May 15, 202510-QQUARTERLY REPORT May 5, 2025DEF 14APROXY STATEMENT Apr 21, 20258-KDelisting Notice Apr 4, 20258-KCompany Update Apr 1, 20258-KMaterial Agreement Mar 31, 202510-KANNUAL REPORT Feb 24, 20258-KDelisting Notice Jan 30, 2025S-1REGISTRATION STATEMENT Jan 24, 20258-KMaterial Agreement · New Debt / Obligation Dec 10, 20248-KMaterial Agreement · New Debt / Obligation Nov 25, 20248-KExecutive Change Nov 19, 202410-QQUARTERLY REPORT Nov 13, 20248-KAgreement Terminated Oct 31, 20248-KAuditor Change Oct 31, 20248-KExecutive Change Oct 21, 20248-KDelisting Notice Oct 2, 20248-KCompany Update Sep 13, 2024S-1/AAMENDMENT NO. 1 TO FORM S-1 Sep 5, 2024S-1REGISTRATION STATEMENT

View all GRML filings on SEC EDGAR ↗